FDA Inspection
Pacira Pharmaceuticals, Inc.Pacira Pharmaceuticals, Inc. – FDA Inspection, Mar 25, 2026
Record Details
This FDA Inspection record concerns Pacira Pharmaceuticals, Inc., with an inspection on March 25, 2026, issued by the Los Angeles District Office, covering animal drugs & feeds.
View Company Profile
ID · 3cc3ff1b-5621-47f6-9873-9cb14163cf74
Inspection Facts
- Inspection number
- 1316070
- FDA center
- Animal Drugs & Feeds
- Outcome
- Form 483 issued
Other FDA inspections of Pacira Pharmaceuticals, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| April 19, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2019 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| March 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 10, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pacira Pharmaceuticals, Inc.
- FDA Inspection 1203460 - 2023-04-19
- FDA Inspection 1102447 - 2019-09-06
- FDA Inspection 1047746 - 2018-03-01
- FDA Inspection 935306 - 2015-07-22
- FDA Inspection 865612 - 2014-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.